Revenue-Cycle Strengthening
Review the workflow from referral through final payment, including coding, authorization, drug and infusion billing, denials, underpayments, A/R, and coverage contracts.
Medical billing performance management for infectious disease practices that need clearer revenue-cycle visibility, stronger operational decisions, and practical ways to identify financial leakage. GrowInfectiousDisease addresses the business complexity of office visits, hospital consults, infusion, OPAT, drug billing, denials, underpayments, and collections through transparent guidance designed for physicians, group leaders, and practice administrators.

Practical revenue-cycle guidance for infectious disease practices managing complex billing, reimbursement, infusion, OPAT, and collections.
Review the workflow from referral through final payment, including coding, authorization, drug and infusion billing, denials, underpayments, A/R, and coverage contracts.
Categorize infectious disease denials by root cause and develop payer-specific appeals addressing coding, authorization, benefit distinctions, and documentation issues.
Compare expected reimbursement with payments for drug, administration, and E/M claims while identifying short-pays, fee schedule issues, and unit or NDC mismatches.
Support charge entry, coding review, claim scrubbing, submission, and rejection clearing for E/M, infusion, and drug claims inside the practice’s existing systems.
Verify eligibility and benefits, distinguish medical and pharmacy benefit requirements, and support prior authorizations for infusions, OPAT courses, and specialty drugs.
Follow aging claims by payer, service type, and balance, with focused attention on high-dollar drug, infusion, hospital consult, and complex outpatient claims.
Infectious disease practices often manage cognitive care alongside infusion, OPAT, drug acquisition, and complex reimbursement workflows. Medical billing performance management helps connect operational activity with financial results by examining documentation, coding, authorization, charge capture, payment accuracy, denials, contracts, and A/R. GrowInfectiousDisease presents transparent guidance and practical tools so practices can apply their own numbers and investigate issues without relying on generalized rates or margins.

A transparent resource hub focused specifically on the economics of independent infectious disease practice.
Guidance is tailored to infectious disease economics, including OPAT, infusion, buy-and-bill, and coverage contracts.
Verified information is distinguished from unknown or practice-specific figures instead of presenting unsupported benchmarks.
Browser-based tools and explainers are available without an email submission or gated access.
Practices can apply their own numbers to evaluate revenue streams, operational decisions, and financial sustainability.
A specialized resource hub for independent infectious disease practice economics.
GrowInfectiousDisease was created in response to the economic complexity of infectious disease practices and the limited business and financial training often provided during fellowship. The resource hub helps infectious disease physicians, group leaders, and practice administrators understand the mechanics behind revenue streams, staffing, OPAT, infusion services, reimbursement, and revenue-cycle management. Its approach combines browser-based tools, financial models, and plain-English explainers. Resources are free and ungated, allowing practices to explore issues affecting sustainability without relying on generalized rates or margins. The platform also makes its limits clear: it does not publish invented rates, drug acquisition costs, payment rates, or margin figures that have not been licensed and verified.
Medical billing performance management examines how effectively a practice turns documented services into accurate, timely reimbursement. For infectious disease practices, that may include office visits, hospital consults, infusion, OPAT, drug claims, authorizations, denials, underpayments, contracts, and A/R. The goal is to understand where revenue is delayed, lost, or left uncollected and connect each issue to an operational cause.
Explore practical guidance for infectious disease revenue-cycle decisions.
Review practical resources, tools, and explainers for infectious disease practice economics and revenue-cycle operations.
To help us assist you faster, please include the reason for your message so the relevant team can reach out as soon as possible.
To help us assist you faster, please include the reason for your message so the relevant team can reach out as soon as possible.